Fuhri Snethlage, C. M. (2024). Type 1 diabetes: A better understanding of the gut-immune axis. [Thesis, fully internal, Universiteit van Amsterdam].
Majait, S. (2024). Bile and bugs: Unraveling the postprandial response of bile acids and gut microbiota in (inherited) metabolic diseases. [Thesis, fully internal, Universiteit van Amsterdam].
Warmbrunn, M. V. (2024). A kick in the guts: Insulin resistance, gut microbiota and cardiometabolic diseases. [Thesis, fully internal, Universiteit van Amsterdam].
Ahdi, M. (2024). CSI Slotervaart: Clinical findings from a multiethnic diabetes cohort in Amsterdam. [Thesis, fully internal, Universiteit van Amsterdam].
Balvers, M. (2024). The human genome and microbiome in cardiometabolic disease: Exploration through sequence-based technologies. [Thesis, fully internal, Universiteit van Amsterdam].
Mak, A. L. (2023). Metabolic dysfunction-associated steatotic liver disease: A wide-angled perspective on a multifaceted problem. [Thesis, fully internal, Universiteit van Amsterdam].
Boulund, U. (2023). Exploring high dimensional data in health and disease: From genome to microbiome. [Thesis, fully internal, Universiteit van Amsterdam].
Habibe, J. J. (2023). The emerging role of FHL2 in metabolism. [Thesis, fully internal, Universiteit van Amsterdam].
Meijnikman, A. S. (2023). A panomics step to unravel the role of gut microbiota in metabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].
Witjes, J. J. (2023). New insights along the gut-liver axis in cardiometabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].
